ASSET PURCHASE AGREEMENT WITH TRIMARAN (Details Narrative) |
Aug. 19, 2019
USD ($)
|
|---|---|
| Asset Purchase Agreement [Member] | TRImaran Pharma Inc [Member] | |
| Asset Acquisition [Line Items] | |
| Payment for purchase of assets | $ 100,000 |
| Liabilities assumed | 68,500 |
| Research and development costs | 168,500 |
| Contingent milestone payment obligation | 3,400,000 |
| WSU License Agreement [Member] | |
| Asset Acquisition [Line Items] | |
| Reimbursement of patent expenses | 75,000 |
| Contingent milestone payment obligation | $ 3,400,000 |
| Percentage of royalties payable to any third party for intellectual property rights | 50.00% |
| Maximum percentage reduction of royalties payable | 50.00% |
| X | ||||||||||
- Definition The element represents achievement payments payable. No definition available.
|
| X | ||||||||||
- Definition The element represents contingent milestone payment obligation. No definition available.
|
| X | ||||||||||
- Definition The element represents maximum percentage reduction of royalties payable. No definition available.
|
| X | ||||||||||
- Definition The element represents percentage of third party royalties payable for reductions in royalties payable. No definition available.
|
| X | ||||||||||
- Definition The element represents reimbursement of patent expenses. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|